The Chemours Company provided earnings guidance for the second quarter of 2024. For the second quarter of 2024, the company expects consolidated Net Sales to increase approximately 15% sequentially, with consolidated Adjusted EBITDA also up approximately 15% compared with first quarter 2024 results.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.82 USD | -3.01% | -6.59% | -21.31% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.31% | 3.7B | |
-1.05% | 74.34B | |
-0.76% | 46.86B | |
+6.80% | 34.35B | |
+9.37% | 18.1B | |
+12.81% | 11.92B | |
-3.01% | 10.43B | |
-20.72% | 10.33B | |
-1.35% | 9.04B | |
-11.01% | 7.84B |
- Stock Market
- Equities
- CC Stock
- News The Chemours Company
- The Chemours Company Provides Earnings Guidance for the Second Quarter of 2024